Next Article in Journal
Rebuilding the Strain Hardening at a Large Strain in Twinned Au Nanowires
Next Article in Special Issue
Nano-Mediated Photodynamic Therapy for Cancer: Enhancement of Cancer Specificity and Therapeutic Effects
Previous Article in Journal
Physicochemical Characterization of FRET-Labelled Chitosan Nanocapsules and Model Degradation Studies
Previous Article in Special Issue
Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells
Article

Temoporfin-in-Cyclodextrin-in-Liposome—A New Approach for Anticancer Drug Delivery: The Optimization of Composition

1
Centre de Recherche en Automatique de Nancy, Centre National de la Recherche Scientifique UMR 7039, Université de Lorraine, Campus Sciences, Boulevard des Aiguillette, 54506 Vandoeuvre-lès-Nancy, France
2
Research Department, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, 54519 Vandoeuvre-lès-Nancy, France
3
Laboratory of Biophysics and Biotechnology, Belarusian State University, 4 Nezavisimosti Avenue, 220030 Minsk, Belarus
4
Biolitec Research GmbH, Otto-Schott-Strasse 15, 07745 Jena, Germany
5
International Sakharov Environmental Institute, Belarusian State University, Dauhabrodskaja 23, 220030 Minsk, Belarus
*
Author to whom correspondence should be addressed.
Nanomaterials 2018, 8(10), 847; https://doi.org/10.3390/nano8100847
Received: 12 September 2018 / Revised: 3 October 2018 / Accepted: 16 October 2018 / Published: 18 October 2018
(This article belongs to the Special Issue Nanomaterials for Photothermal/Photodynamic Therapy)
The main goal of this study was to use hybrid delivery system for effective transportation of temoporfin (meta-tetrakis(3-hydroxyphenyl)chlorin, mTHPC) to target tissue. We suggested to couple two independent delivery systems (liposomes and inclusion complexes) to achieve drug-in-cyclodextrin-in-liposome (DCL) nanoconstructs. We further optimized the composition of DCLs, aiming to alter in a more favorable way a distribution of temoporfin in tumor tissue. We have prepared DCLs with different compositions varying the concentration of mTHPC and the type of β-cyclodextrin (β-CD) derivatives (Hydroxypropyl-, Methyl- and Trimethyl-β-CD). DCLs were prepared by thin-hydration technique and mTHPC/β-CD complexes were added at hydration step. The size was about 135 nm with the surface charge of (−38 mV). We have demonstrated that DCLs are stable and almost all mTHPC is bound to β-CDs in the inner aqueous liposome core. Among all tested DCLs, trimethyl-β-CD-based DCL demonstrated a homogenous accumulation of mTHPC across tumor spheroid volume, thus supposing optimal mTHPC distribution. View Full-Text
Keywords: temoporfin; drug-in-cyclodextrin-in-liposome; nanoparticles; multicellular tumor spheroids; flow cytometry; photodynamic therapy temoporfin; drug-in-cyclodextrin-in-liposome; nanoparticles; multicellular tumor spheroids; flow cytometry; photodynamic therapy
Show Figures

Graphical abstract

MDPI and ACS Style

Yakavets, I.; Lassalle, H.-P.; Scheglmann, D.; Wiehe, A.; Zorin, V.; Bezdetnaya, L. Temoporfin-in-Cyclodextrin-in-Liposome—A New Approach for Anticancer Drug Delivery: The Optimization of Composition. Nanomaterials 2018, 8, 847. https://doi.org/10.3390/nano8100847

AMA Style

Yakavets I, Lassalle H-P, Scheglmann D, Wiehe A, Zorin V, Bezdetnaya L. Temoporfin-in-Cyclodextrin-in-Liposome—A New Approach for Anticancer Drug Delivery: The Optimization of Composition. Nanomaterials. 2018; 8(10):847. https://doi.org/10.3390/nano8100847

Chicago/Turabian Style

Yakavets, Ilya, Henri-Pierre Lassalle, Dietrich Scheglmann, Arno Wiehe, Vladimir Zorin, and Lina Bezdetnaya. 2018. "Temoporfin-in-Cyclodextrin-in-Liposome—A New Approach for Anticancer Drug Delivery: The Optimization of Composition" Nanomaterials 8, no. 10: 847. https://doi.org/10.3390/nano8100847

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop